Eleven Biotherapeutics Selected to Present
Handpicked from public biotech companies whose innovations are driving stock prices, Eleven Biotherapeutics, Inc. will present a company over view at the 22nd Annual NewsMakers in the Biotech Industry Conference on Thursday, September 10. Abbie Celniker, PhD, President and Chief Executive Officer of the clinical-stage company will be in New York City to demonstrate how Eleven Biotherapeutics is developing protein therapeutics to treat challenging diseases of the eye.
Serving as a networking opportunity for business executives and investors, the annual conference has gathered over 500 delegates managing over $480 billion in equity assets to showcase accomplished public biotech companies. To be held at the Millennium Broadway Hotel & Conference Center, NewsMakers will attract corporate and investment communities with over $65 billion dedicated to healthcare and biotech.
In addition to Eleven Biotherapeutics, over 75 biotech companies will present including Esperion Therapeutics Inc., Adamas Pharmaceuticals Inc. and BioSpecifics Technologies Corp. The event is sponsored by Campbell Alliance, WBB Securities, Laidlaw & Company, Torreya Partners, Trout Group and the Biotechnology Industry Organization.
Access to a live webcast of Eleven Biotherapeutics’ presentation will be available on the Investors & Media section of their website at www.elevenbio.com. For more information and to register for the conference, visit http://www.biocentury.com/conferences/newsmakers/dates.
